Lung disease inhalers
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Breast Cancer ~ Swine Flu ~ Lung Cancer ~ Heart attack ~ Pregnancy ~ All Health Topics
Home / Health News / 2008 / September 2008 / September 24, 2008
Lung disease-inhalers can cause heart attacks
RSS / Print / Comments
Wake Forest University

Vitamin D protects obese women against endometrial cancer

Now, alternate therapy for adults with poorly controlled asthma

Marriott International Announces Leadership Positions for Asia Pacific, Middle East and Africa

More on Wake Forest University

Heart attack

European Medicines Agency approves TWYNSTA® (telmisartan plus amlodipine) a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours

More strokes, fewer heart attacks with carotid stents: Study

Insulin resistance may be linked to stroke risk

More on Heart attack

Health News

New study confirms smoking, cancer link (reissue)
Taking up smoking results in epigenetic changes associated with the development of cancer, UK scientists have reported. ANI

Blame your mom for your muffin top or thunder thighs
A new study by an international team of researchers, including Cambridge and Oxford experts, has revealed that our propensity to be apple or pear-shaped is at least partly in our genes. ANI

Chemicals in mother's blood linked to child's obesity
A team of scientists has revealed that babies whose mothers had relatively high levels of the chemical DDE in their blood were more likely to both grow rapidly during their first 6 months and to have a high body ma*s index (BMI) by 14 months. ANI

Lung disease-inhalers can cause heart attacks

Inhalers prescribed for a lung disease can cause heart attacks, a shocking new research has found.

London, Sept 24 : Inhalers prescribed for a lung disease can cause heart attacks, a shocking new research has found.

According to the study, anticholinergic drugs contained in the inhalers could increase the risk of a heart attack, cardiovascular death or stroke by more than 50 percent.

The inhalers are helpful for people with chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema, to breathe.

They open up the airways by relaxing muscles, which allows air to get in and out of the patient's lungs more easily.

To reach the conclusion, the researchers looked at the inhalers ipratropium (Atrovent) and tiotropium (Spiriva). The meta-analysis examined at 17 medical trials involved a total of 14,783 patients who were using the inhalers for more than 30 days.

The study has been published in the Journal of the American Medical Association (JAMA).

"Inhaled anticholinergic use for more than 30 days significantly increases the risk of cardiovascular death, myocardial infarction (heart attack), or stroke in patients with COPD by approximately 58 percent," the Daily Express quoted the researchers, as saying.

The research was carried out by experts from the Wake Forest University School of Medicine in North Carolina and Dr Yoon Loke, from the University of East Anglia in Norwich.

ANI

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2018 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us